In October 2021, industry leaders from 15 of the leading organisations working in the Australian medical cannabis industry met to discuss forming a new association, the Emerging Therapeutics Association of Australia (ETAA).
There was broad agreement that systemic improvements were needed to enhance safe access for patients within the current legislative framework, while also supporting a well-functioning medical cannabis industry in Australia as it grows.
To deliver these improvements, ETAA aims to provide a constructive and unified voice to government direct from industry.
To embed emerging therapies as part of Australia’s healthcare landscape with safe, affordable and legal treatment pathways readily available to Australian patients.
Bringing together all aspects of emerging therapies, from the licensed cultivation, manufacturing, distribution and research, our mission is to advance government legislation to meet the needs of Australian patients and prescribers by making legal access the preferred patient choice.
Supply chain efficiency, transparency and strict control that generates confidence in the industry, while facilitating access to suitable treatments to meet increasing demand
Industry advocacy and responsible oversight
Patient and prescriber education